Olink Holding AB (OLK) enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform

Go back to Olink Holding AB (OLK) enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform

Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform

July 13, 2021 8:00 AM EDT

UPPSALA, Sweden, July 13, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that deCODE genetics, a global leader in analyzing and understanding the human genome, will have internal access to the Olink® Explore 3072 platform, comprised of approximately 3,000 high quality protein assays with a Next Generation Sequencing (NGS) read-out.

Through an agreement between the two companies, deCODE genetics will be one of the first companies to adopt and internalize the new Explore 3072 proteomics platform and will act as an early testing site for its use. In doing so,... More